Alliance Global Partners analyst Ben Haynor maintains Icecure Medical (NASDAQ:ICCM) with a Buy and raises the price target from $1.9 to $2.9.
Alliance Global Partners Maintains Buy on Icecure Medical, Raises Price Target to $2.9
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.